Literature DB >> 23891961

Lactobacillus plantarum TN8 exhibits protective effects on lipid, hepatic and renal profiles in obese rat.

Riadh Ben Salah1, Imen Trabelsi, Khaled Hamden, Hichem Chouayekh, Samir Bejar.   

Abstract

This study aimed to first investigate the immuno-modulatory effects of six newly isolated lactic acid bacteria (LAB) on the peripheral blood mononuclear cells (PBMC) of Wistar rats. Except for Lactobacillus plantarum TN8, all the other strains were noted to induce high levels of pro-inflammatory cytokine IL-12 and low levels of anti-inflammatory cytokine IL-10. The strains also generated low ratios of IL-10/IL-12 cytokine. Strain TN8 was, on the other hand, noted to induce an increase in anti-inflammatory IL-10 cytokine secretion rates and a decrease in pro-inflammatory IL-12, IFN-γ and TNF-α cytokine production. The oral administration of TN8 improved the hepatic and urinary functions of obese rats by inducing decreases (P < 0.05) in alanine amino transferase (ALAT), gamma glutamyl transferase (GGT), plasmatic triglycerides, total cholesterol concentrations, creatinine, urea, and body weight when compared to the control group of animals that underwent an increase in aspartate amino transferase (ASAT) and high density lipoprotein (HDL). Overall, the findings indicate that strain TN8 exhibited a number of attractive properties that might open new promising opportunities for the improvement of various parameters related to animal health performance and the avoidance of antibiotics and drugs as promoting factors.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Blood; Cytokines; Kidney; Lactic acid bacteria; Liver; Obesity

Mesh:

Substances:

Year:  2013        PMID: 23891961     DOI: 10.1016/j.anaerobe.2013.07.003

Source DB:  PubMed          Journal:  Anaerobe        ISSN: 1075-9964            Impact factor:   3.331


  8 in total

Review 1.  Probiotic strains and mechanistic insights for the treatment of type 2 diabetes.

Authors:  Christiane S Hampe; Christian L Roth
Journal:  Endocrine       Date:  2017-10-19       Impact factor: 3.633

2.  In vitro importance of probiotic Lactobacillus plantarum related to medical field.

Authors:  Mariadhas Valan Arasu; Naif Abdullah Al-Dhabi; Soundharrajan Ilavenil; Ki Choon Choi; Srisesharam Srigopalram
Journal:  Saudi J Biol Sci       Date:  2015-10-09       Impact factor: 4.219

Review 3.  Effect of probiotic Lactobacillus on lipid profile: A systematic review and meta-analysis of randomized, controlled trials.

Authors:  Yucheng Wu; Qingqing Zhang; Yin Ren; Zhongbao Ruan
Journal:  PLoS One       Date:  2017-06-08       Impact factor: 3.240

4.  Lactobacillus Strains Alleviated Hyperlipidemia and Liver Steatosis in Aging Rats via Activation of AMPK.

Authors:  Lee-Ching Lew; Yan-Yan Hor; Mohamad-Hafis Jaafar; Amy-Sie-Yik Lau; Boon-Kiat Lee; Li-Oon Chuah; Kien-Pong Yap; Azali Azlan; Ghows Azzam; Sy-Bing Choi; Min-Tze Liong
Journal:  Int J Mol Sci       Date:  2020-08-16       Impact factor: 5.923

Review 5.  Anti-Inflammatory and Immunomodulatory Effects of Probiotics in Gut Inflammation: A Door to the Body.

Authors:  Fernanda Cristofori; Vanessa Nadia Dargenio; Costantino Dargenio; Vito Leonardo Miniello; Michele Barone; Ruggiero Francavilla
Journal:  Front Immunol       Date:  2021-02-26       Impact factor: 7.561

6.  Difference in oral microbial composition between chronic periodontitis patients with and without diabetic nephropathy.

Authors:  Dongxue Zhang; Wenyan Liu; Li Peng; Haiyan Wang; Mei Lin; Yufeng Li; Zuomin Wang
Journal:  BMC Oral Health       Date:  2022-01-16       Impact factor: 2.757

Review 7.  Possible Benefits of Faecalibacterium prausnitzii for Obesity-Associated Gut Disorders.

Authors:  Tatiani Uceli Maioli; Esther Borras-Nogues; Licia Torres; Sara Candida Barbosa; Vinicius Dantas Martins; Philippe Langella; Vasco Ariston Azevedo; Jean-Marc Chatel
Journal:  Front Pharmacol       Date:  2021-12-02       Impact factor: 5.810

8.  Lactobacillus rhamnosus PL1 and Lactobacillus plantarum PM1 versus placebo as a prophylaxis for recurrence urinary tract infections in children: a study protocol for a randomised controlled trial.

Authors:  Maria Daniel; Hanna Szymanik-Grzelak; Agnieszka Turczyn; Małgorzata Pańczyk-Tomaszewska
Journal:  BMC Urol       Date:  2020-10-23       Impact factor: 2.264

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.